American Family Children's Hospital
SHARE TEXT

UW Health ACO Governance

ACO Name and Location

 

UW Health ACO

University Crossing Building

749 University Row, Suite 251

Madison, WI 53705

 

ACO Primary Contact

 

Jonathan Jaffery, MD

President and CEO, UW Health ACO

Email:  uwhealthaco@uwhealth.org

Phone:  (608) 821-4998

 

Organizational Information

 

ACO participants:

ACO participants in joint ventures between ACO professionals and hospitals:

 

No participants are involved in a joint venture between ACO professionals and hospitals.

 

ACO governing body:

  • Robert Golden, MD, Dean, University of Wisconsin School of Medicine and Public Health
  • Jeff Grossman, MD, CEO, UW Health
  • Jonathan Jaffery, MD, President and Chief Executive Officer, UW Health ACO; Chief Population Health Officer, UW Health
  • Ron Sliwinski, President, UW Hospitals and Chief of Clinical Operations
  • Ken Mount, CFO, University of Wisconsin School of Medicine and Public Health
  • David Kindig, MD, Medicare Beneficiary

Key ACO clinical and administrative leadership:

  • ACO Executive: Jonathan Jaffery, MD
  • Medical Director: Jeff Huebner, MD
  • Compliance Official: Dan Brzozowski

Associated committees and committee leadership:

  • UW Health ACO Finance Committee: Robert O'Keefe, Chair
  • UW Health ACO Administration and Operations Team: Jonathan Jaffery, MD, Co-Chair; Stephanie Berkson, Co-Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals

Shared Savings and Losses

 

Amount of Shared Savings/Losses

  • Performance Year 2013: $0
  • Performance Year 2014: $0

How Shared Savings are Distributed

 

Shared Savings are reinvested back into care coordination activities. Any remaining funds are distributed back to the participant organizations.

 

Quality Performance Results

 

 

Measure number

 

Performance measure

2013 reporting period

2014 reporting period

ACO

performance rate

Mean performance rate for all ACOs

ACO

performance rate

Mean performance rate for all ACOs

ACO #1

Getting Timely Care, Appointments, and Information

82.05

81.48

81.94

80.13

ACO #2

How Well Your Doctors Communicate

93.23

92.96

92.89

92.39

ACO #3

Patients' Rating of Doctor

91.91

92.06

92.46

91.58

ACO #4

Access to Specialists

84.08

85.12

86.54

83.97

ACO #5

Health Promotion and Education

58.05

58.38

58.62

58.29

ACO #6

Shared Decision Making

76.05

74.53

79.04

74.60

ACO #7

Health Status/Functional Status

72.49

71.12

73.93

71.10

ACO #8^

Risk Standardized, All Condition Readmissions

13.51

14.90

14.75

15.15

ACO #9^

ASC Admissions: COPD or Asthma in Older Adults

0.73

1.17

0.69

1.08

ACO #10^

ASC Admission: Heart Failure

0.97

1.20

1.03

1.19

ACO #11

Percent of PCPs who Qualified for EHR Incentive Payment

87.69

66.21

97.93

76.71

ACO #12

Medication Reconciliation

0.00

73.56

73.12

82.61

ACO #13

Falls: Screening for Fall Risk

22.67

39.57

68.59

45.60

ACO #14

Influenza Immunization

85.77

56.93

85.99

57.51

ACO #15

Pneumococcal Vaccination

92.17

54.76

92.50

55.03

ACO #16

Adult Weight Screening and Follow-up

56.06

61.61

72.97

66.75

ACO #17

Tobacco Use Assessment and Cessation Intervention

92.27

84.01

97.81

86.79

ACO #18

Depression Screening

0.34

31.19

54.72

39.27

ACO #19

Colorectal Cancer Screening

79.31

59.30

83.76

56.14

ACO #20

Mammography Screening

69.39

62.05

83.53

61.41

ACO #21

Proportion of Adults who had blood pressure screened in past 2 years

78.17

74.25

67.52

60.24

ACO #22

Hemoglobin A1c Control (HbA1c) (<8 percent)

81.03

*N/A

78.48

*N/A

ACO #23

Low Density Lipoprotein (LDL) (<100 mg/dL)

70.47

*N/A

*N/A

*N/A

ACO #24

Blood Pressure (BP) <140/90

75.43

*N/A

76.79

*N/A

ACO #25

Tobacco Non Use

89.22

*N/A

87.76

*N/A

ACO #26

Aspirin Use

91.16

*N/A

95.12

*N/A

ACO #27^

Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent)

9.27

22.11

8.98

20.35

ACO #28

Percent of beneficiaries with hypertension whose BP <140/90

75.60

67.79

75.99

68.02

ACO #29

Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg/dl

65.39

55.44

*N/A

*N/A

ACO #30

Percent of beneficiaries with IVD who use Aspirin or other antithrombotic

91.78

76.35

93.67

80.79

ACO #31

Beta-Blocker Therapy for LVSD

91.60

79.82

97.44

82.71

ACO #32

Drug Therapy for Lowering LDL Cholesterol

82.08

*N/A

*N/A

*N/A

ACO #33

ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or LVSD

88.73

*N/A

82.03

*N/A

 

^: These measures are reverse-scored. Lower scores for these measure indicate better performance.

*N/A: CMS has determined that ACOs should not publicly report on these measures.

 

More information on how to interpret scores on the above quality performance measures (pdf)

 

UW Health ACO Compliance Reporting

 

Please submit concerns to:

 

Dan Brzozowski, Compliance Officer, UW Health ACO, Inc.

301 S Westfield Rd. Suite 320

Madison, WI 53717

ACOCompliance@uwhealth.org

 

Anonymous UW Health ACO Reporting Hotline (8am–5pm Central, Monday-Friday)

  • (608) 821-4130 (local)
  • (888) 225-8282 (toll free)